GSTM1 and colorectal cancer: Including age, sex, MCV, platelets and f‐Hb in a survival analysis model to predict the risk of colorectal cancer reduces false positives compared to a simple binary cut off f‐Hb ≥ 10 μgHb/g which may decrease the burden on endoscopy whilst maintaining diagnostic accuracy.